Home
Scholarly Works
Dapagliflozin reduced worsening HF or CV death in...
Journal article

Dapagliflozin reduced worsening HF or CV death in HF with reduced ejection fraction.

Authors

Sullivan K; Van Spall HGC

Journal

Annals of Internal Medicine, Vol. 172, No. 4,

Publisher

American College of Physicians

Publication Date

February 18, 2020

DOI

10.7326/acpj202002180-016

ISSN

1056-8751

Contact the Experts team